Covalenttoxin vs SpotitEarly

Covalenttoxin vs SpotitEarly, compared side by side on 9 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Covalenttoxin is on 6/100 and SpotitEarly on 53/100.

Covalenttoxin logo
CovalenttoxinAI-driven platform for accelerating the discovery and design of novel toxins and therapeutic molecules.
Try Covalenttoxin
SpotitEarly logo
SpotitEarlyScent-based multi-cancer early detection screening test using AI and bio-detectors.
Try SpotitEarly

Where each one leads

Covalenttoxin

Leads on none of the measures we hold for both companies.

SpotitEarly

  • our overall score: 53/100 against 6/100
  • agent readiness: 45/100 against 21/100

At a glance

MeasureCovalenttoxinSpotitEarly
What it isAI-driven platform for accelerating the discovery and design of novel toxins and therapeutic molecules.Scent-based multi-cancer early detection screening test using AI and bio-detectors.
CategoryAI-Driven Drug Discovery, Biotech, MedTech, Foundation ModelHealthcare, HealthTech, MedTech, Biotech
Sells toBusiness modelB2BB2B
OfferingPlatformSoftware | services
FoundedNot published2021
HeadquartersNot publishedTel Aviv, Israel
StatusActiveActive

Size, funding and growth

MeasureCovalenttoxinSpotitEarly
EmployeesNot published17
Headcount growthLast 12 monthsNot published+104.3%
Total fundingNot published$6.2M
Latest roundNot publishedSeed
LinkedIn followersNot published516

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCovalenttoxinSpotitEarly
StartupHub scoreOur 0-100 rating6/10053/100
TractionNot published47/100
TeamNot published50/100
Search visibility2/10030/100
QualityNot published58/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)D (45/100)
Domain ratingLink authority, 0-100Not published29/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCovalenttoxinSpotitEarly
CMSNot detectedWix
AnalyticsNot detectedGoogle Analytics 4, Google Tag Manager
Support stackNot detectedHubSpot
Open sourceNoYes

Covalenttoxin vs SpotitEarly: common questions

Which is better, Covalenttoxin or SpotitEarly?

On our 0-100 score SpotitEarly rates higher (53/100 against 6/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 9 data points above: read the rows that match what you are buying for.

How do Covalenttoxin and SpotitEarly compare on the numbers?

SpotitEarly leads on our overall score (53/100 against 6/100), agent readiness (45/100 against 21/100).

Read the full Covalenttoxin review and pricing or the SpotitEarly review and pricing. You can also browse other Covalenttoxin alternatives we track.